«S2RPgrmc1: the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling». Expert Opinion on Drug Metabolism & Toxicology8 (3): 361-370. Mar 2012. PMID22292588. doi:10.1517/17425255.2012.658367.
«Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy». Medicinal Research Reviews34 (3): 532-566. May 2014. PMID23922215. doi:10.1002/med.21297.
«Pharmacology of sigma (σ) receptor ligands from a behavioral perspective». Current Pharmaceutical Design18 (7): 863-874. 2012. PMID22288408. doi:10.2174/138161212799436458.
«Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals». Current Pharmaceutical Design12 (30): 3857-3876. 2006. PMID17073684. doi:10.2174/138161206778559614.
«Potential applications for sigma receptor ligands in cancer diagnosis and therapy». Biochimica et Biophysica Acta (BBA) - Biomembranes1848 (10): 2703-14. Aug 2014. PMID25173780. doi:10.1016/j.bbamem.2014.08.022.
van Waarde A, Rybczynska AA, Ramakrishnan NK, Ishiwata K, Elsinga PH, Dierckx RA (Aug 2014). "Potential applications for sigma receptor ligands in cancer diagnosis and therapy". Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848 (10): 2703–14. doi:10.1016/j.bbamem.2014.08.022. PMID 25173780
«S2RPgrmc1: the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling». Expert Opinion on Drug Metabolism & Toxicology8 (3): 361-370. Mar 2012. PMID22292588. doi:10.1517/17425255.2012.658367.
Ahmed IS, Chamberlain C, Craven RJ (Mar 2012). "S2RPgrmc1: the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling". Expert Opinion on Drug Metabolism & Toxicology. 8 (3): 361–370. doi:10.1517/17425255.2012.658367. PMID 22292588
«Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy». Medicinal Research Reviews34 (3): 532-566. May 2014. PMID23922215. doi:10.1002/med.21297.
Huang YS, Lu HL, Zhang LJ, Wu Z (May 2014). "Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy". Medicinal Research Reviews. 34 (3): 532–566. doi:10.1002/med.21297. PMID 23922215
Huang YS, Lu HL, Zhang LJ, Wu Z (May 2014). "Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy". Medicinal Research Reviews. 34 (3): 532–566. doi:10.1002/med.21297. PMID 23922215
«Pharmacology of sigma (σ) receptor ligands from a behavioral perspective». Current Pharmaceutical Design18 (7): 863-874. 2012. PMID22288408. doi:10.2174/138161212799436458.
«Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals». Current Pharmaceutical Design12 (30): 3857-3876. 2006. PMID17073684. doi:10.2174/138161206778559614.
«Potential applications for sigma receptor ligands in cancer diagnosis and therapy». Biochimica et Biophysica Acta (BBA) - Biomembranes1848 (10): 2703-14. Aug 2014. PMID25173780. doi:10.1016/j.bbamem.2014.08.022.